Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News and Analysis

Ottawa seeks source of medical marijuana

Patrick Sullivan
CMAJ July 11, 2000 163 (1) 74-74-a;
Patrick Sullivan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

The federal government's recent decision to establish a Canadian source of quality and affordable research-grade marijuana is particularly good news for the 37 Canadians who have exemptions that allow them to smoke the drug because of illness.

"This is definitely a step in the right direction," says Alison Myrden of Burlington, Ont., who is allowed to use marijuana because she has multiple sclerosis. "I hope life will be a bit less complicated because I would no longer have to go to the streets." FIGURE

Figure1

Figure.

Myrden is among the handful of MS patients who develop tic douloureux (trigeminal neuralgia), which causes "excruciating" facial pain. Although marijuana helps control her pain, she has had a hard time finding the drug. When she could find it, the cost was $400 a month. She now receives free marijuana from the Compassion Club Society of British Columbia (see CMAJ 1999;161[8]:1024), but she says the strength and the amount have not been adequate to control her pain. Under the Health Canada plan, a grower would establish a processing operation, provide quality control and distribute the marijuana to "authorized recipients." Myrden says the greatest need is for an "appropriate, consistent and affordable source for our medication." The marijuana produced for the government will also be used in clinical trials.

Myrden is unsure what the government marijuana will cost, but hopes it will be cheaper than the $300 to $400 per month she used to pay. "I hope the government will take into consideration the fact that most exemptees are either dying or on full disability, and affordability is a key factor," she says.

As for concerns about possible detrimental effects from exempting some people from the provisions of section 56 of Canada's Controlled Drugs and Substances Act, Myrden responds: "Those of us who use this drug medicinally are not potheads or drug addicts. We are sick and dying people."

PreviousNext
Back to top

In this issue

CMAJ
Vol. 163, Issue 1
11 Jul 2000
  • Table of Contents
  • Index by author
  • Canadian Adverse Drug Reaction Newsletter (85-92)

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ottawa seeks source of medical marijuana
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Ottawa seeks source of medical marijuana
Patrick Sullivan
CMAJ Jul 2000, 163 (1) 74-74-a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Ottawa seeks source of medical marijuana
Patrick Sullivan
CMAJ Jul 2000, 163 (1) 74-74-a;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • More medical students for Dalhousie
  • Stressed parents at “loggerheads” with children, report says
  • Number of medical school applicants drops on both sides of border
Show more News and Analysis

Similar Articles

Collections

  • Topics
    • Pain
    • Drug regulation
    • Cannabis

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire